Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-06

Clinical Trial Update: Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy of immunosuppressive therapy for IgA nephropathy in patients with stage 3 or 4 chronic kidney disease is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Air Force Military Medical University, China | Conditions: Glomerulonephritis, IGA | Phase 3 | Status: RECRUITING